New York City based Cambrian BioPharma is raising $100,775,000.00 in New Equity Investment.
New York, NY – According to filings with the U.S. Securities and Exchange Commission, Cambrian BioPharma is raising $100,775,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, James Peyer played…
